Baird Financial Group’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,018
| Closed | -$436K | – | 1774 |
|
|
2024
Q4 | $436K | Sell |
36,018
-8,388
| -19% | -$102K | ﹤0.01% | 1425 |
|
|
2024
Q3 | $652K | Buy |
44,406
+20,504
| +86% | +$301K | ﹤0.01% | 1291 |
|
|
2024
Q2 | $345K | Buy |
+23,902
| New | +$345K | ﹤0.01% | 1514 |
|
|
2023
Q4 | – | Sell |
-38,612
| Closed | -$434K | – | 1736 |
|
|
2023
Q3 | $434K | Buy |
+38,612
| New | +$434K | ﹤0.01% | 1384 |
|
|
2022
Q4 | – | Sell |
-47,406
| Closed | -$589K | – | 1704 |
|
|
2022
Q3 | $589K | Buy |
47,406
+843
| +2% | +$10.5K | ﹤0.01% | 1231 |
|
|
2022
Q2 | $914K | Buy |
46,563
+261
| +0.6% | +$5.12K | ﹤0.01% | 1106 |
|
|
2022
Q1 | $1.21M | Buy |
46,302
+4,738
| +11% | +$124K | ﹤0.01% | 1062 |
|
|
2021
Q4 | $1.18M | Sell |
41,564
-592
| -1% | -$16.8K | ﹤0.01% | 1140 |
|
|
2021
Q3 | $1.34M | Buy |
42,156
+2,984
| +8% | +$95.1K | ﹤0.01% | 1087 |
|
|
2021
Q2 | $1.36M | Sell |
39,172
-6,979
| -15% | -$242K | ﹤0.01% | 1058 |
|
|
2021
Q1 | $1.36M | Sell |
46,151
-1,812
| -4% | -$53.4K | ﹤0.01% | 1020 |
|
|
2020
Q4 | $1.47M | Buy |
47,963
+539
| +1% | +$16.5K | ﹤0.01% | 893 |
|
|
2020
Q3 | $1.33M | Buy |
47,424
+98
| +0.2% | +$2.74K | ﹤0.01% | 862 |
|
|
2020
Q2 | $1.02M | Buy |
47,326
+9,615
| +25% | +$206K | ﹤0.01% | 929 |
|
|
2020
Q1 | $844K | Buy |
37,711
+335
| +0.9% | +$7.5K | ﹤0.01% | 929 |
|
|
2019
Q4 | $1.1M | Sell |
37,376
-881
| -2% | -$26K | ﹤0.01% | 940 |
|
|
2019
Q3 | $1.02M | Buy |
38,257
+3,760
| +11% | +$100K | ﹤0.01% | 967 |
|
|
2019
Q2 | $1.17M | Buy |
34,497
+10,331
| +43% | +$349K | ﹤0.01% | 937 |
|
|
2019
Q1 | $775K | Buy |
+24,166
| New | +$775K | ﹤0.01% | 930 |
|